Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Müller

Showing results (221-230 of 301) with videos related to

Pageof 31
Sort By:
Annals of the Rheumatic Diseases|August 2, 2015
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR databaseElina G Wirz, Veronika K Jaeger, Yannick Allanore, et al.
Nature Medicine|November 10, 2009
Synovial fibroblasts spread rheumatoid arthritis to unaffected jointsStephanie Lefèvre, Anette Knedla, Christoph Tennie, et al.
Annals of the Rheumatic Diseases|May 21, 2013
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA studyDae Hyun Yoo, Pawel Hrycaj, Pedro Miranda, et al.
Annals of the Rheumatic Diseases|December 21, 2012
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational studyMuriel Elhai, Marine Meunier, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|June 19, 2021
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohortMichael Hughes, Calvin Heal, Jörg Henes, et al.
Plos One|October 6, 2016
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR StudyVeronika K Jaeger, Elina G Wirz, Yannick Allanore, et al.
Rheumatology (Oxford, England)|May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR databaseMichele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Annals of the Rheumatic Diseases|March 24, 2019
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa studySudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseasesMatilde Bandeira, Ana Vieira, Vera Guimarães, et al.
Pageof 31

Showing results (221-230 of 301) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|August 2, 2015
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR databaseElina G Wirz, Veronika K Jaeger, Yannick Allanore, et al.
Nature Medicine|November 10, 2009
Synovial fibroblasts spread rheumatoid arthritis to unaffected jointsStephanie Lefèvre, Anette Knedla, Christoph Tennie, et al.
Annals of the Rheumatic Diseases|May 21, 2013
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA studyDae Hyun Yoo, Pawel Hrycaj, Pedro Miranda, et al.
Annals of the Rheumatic Diseases|December 21, 2012
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational studyMuriel Elhai, Marine Meunier, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|June 19, 2021
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohortMichael Hughes, Calvin Heal, Jörg Henes, et al.
Plos One|October 6, 2016
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR StudyVeronika K Jaeger, Elina G Wirz, Yannick Allanore, et al.
Rheumatology (Oxford, England)|May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR databaseMichele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Annals of the Rheumatic Diseases|March 24, 2019
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa studySudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseasesMatilde Bandeira, Ana Vieira, Vera Guimarães, et al.
Pageof 31